1. Home
  2. IBRX vs TRUP Comparison

IBRX vs TRUP Comparison

Compare IBRX & TRUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBRX
  • TRUP
  • Stock Information
  • Founded
  • IBRX 2014
  • TRUP 2000
  • Country
  • IBRX United States
  • TRUP United States
  • Employees
  • IBRX N/A
  • TRUP N/A
  • Industry
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • TRUP Medical Specialities
  • Sector
  • IBRX Health Care
  • TRUP Health Care
  • Exchange
  • IBRX Nasdaq
  • TRUP Nasdaq
  • Market Cap
  • IBRX 2.3B
  • TRUP 2.1B
  • IPO Year
  • IBRX N/A
  • TRUP 2014
  • Fundamental
  • Price
  • IBRX $2.81
  • TRUP $49.38
  • Analyst Decision
  • IBRX Strong Buy
  • TRUP Buy
  • Analyst Count
  • IBRX 5
  • TRUP 6
  • Target Price
  • IBRX $11.40
  • TRUP $53.80
  • AVG Volume (30 Days)
  • IBRX 7.3M
  • TRUP 580.3K
  • Earning Date
  • IBRX 08-11-2025
  • TRUP 08-07-2025
  • Dividend Yield
  • IBRX N/A
  • TRUP N/A
  • EPS Growth
  • IBRX N/A
  • TRUP N/A
  • EPS
  • IBRX N/A
  • TRUP N/A
  • Revenue
  • IBRX $31,222,000.00
  • TRUP $1,321,538,000.00
  • Revenue This Year
  • IBRX $567.98
  • TRUP $11.30
  • Revenue Next Year
  • IBRX $160.56
  • TRUP $6.01
  • P/E Ratio
  • IBRX N/A
  • TRUP N/A
  • Revenue Growth
  • IBRX 10238.41
  • TRUP 14.08
  • 52 Week Low
  • IBRX $1.83
  • TRUP $28.73
  • 52 Week High
  • IBRX $7.48
  • TRUP $57.90
  • Technical
  • Relative Strength Index (RSI)
  • IBRX 51.33
  • TRUP 41.85
  • Support Level
  • IBRX $2.68
  • TRUP $51.07
  • Resistance Level
  • IBRX $3.00
  • TRUP $53.61
  • Average True Range (ATR)
  • IBRX 0.16
  • TRUP 2.14
  • MACD
  • IBRX -0.00
  • TRUP -0.92
  • Stochastic Oscillator
  • IBRX 62.00
  • TRUP 0.98

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

Share on Social Networks: